More that 4,000 health care professionals, researchers and people with a special interest in breast cancer are expected to attend the 25th Annual San Antonio Breast Cancer Symposium, Dec. 11-14 at the Henry B. Gonzalez Convention Center, 200 E. Market. This symposium is internationally recognized as the leading meeting, which focuses on breast cancer and understanding its basic biology and clinical efforts toward prevention and treatment.
Oral sessions and abstract posters will be presented during the symposium. Some will reveal, for the first time, new and late breaking data, including promising information from clinical trials and studies and recent diagnostic developments.
In addition to the nearly 450 different presentations, four mini-symposia on special topics, six plenary speakers and a satellite symposium, on optimizing treatment strategies in breast cancer, will follow the regular meeting.
Schedule of mini symposia:
3 p.m., Dec. 11 -- Aromatase Inhibitors: A Journey in Molecular Therapeutics
2:30 p.m. Dec. 12 -- Epithelial/Stromal Interactions in Breast Cancer Development
3 p.m. Dec. 13 -- The Changing Face of Adjuvant Therapy
10 a.m. Dec. 14 -- Genetics of Breast Cancer: BRCA 1 and 2 and Beyond
Schedule of plenary talks:
9:30 a.m. Dec. 11 -- Growth Factor Pathways and Endocrine Resistance Robert Nicholson, Ph.D., Tenovus Centre for Cancer Research, Cardiff, Wales, U.K.
2 p.m. Dec. 12 -- CDNA Array Data: Genomics to Prognosis Stephen Friend, M.D., Ph.D., Rosetta Inpharmatics, Merck Research, West Point, Pa.
9 a.m. Dec. 13 -- Clinical Application of Proteomics in Cancer Prevention and Treatment Emanual Petricoin, Ph.D., F.D.A., Bethesda, Md.
2:30 p.m. Dec. 13 -- Breast Cancer Risk with E+P Hormone Replacement Therapy: Further Analysis of the Womens Health Initiative Data Rowan Chlebowski, M.D., Ph.D., Harbor-UCLA Medical Center, Torrance, Calif.
9 a.m. Dec. 14 -- Validity of Screening Mammography Trials Stephen Feig, M.D., Mount Sinai School of Medicine, New York City
9:30 a.m., Dec. 14 -- Limitations in the Interpretation of the Mammography Trials I. Craig Henderson, M.D., University of California, San Francisco
The Annual William L. McGuire Memorial Lecture will be given by Michael Baum, M.D., University College, London, U.K. The title of his presentation is The Biological Fallout From 30 Years of Clinical Trials for Early Breast Cancer. His lecture will be presented at 11 a.m. Thursday, Dec. 12.
During the symposium, on the evening of Dec. 12, the Susan G. Komen Breast Cancer Foundation will hold its Brinker Breast Cancer Awards Dinner. A satellite symposium at the Marriott Rivercenter Hotel, 101 Bowie St., will follow the regular session on Saturday, Dec. 14, covering the topic "Optimizing Treatment Strategies in Breast Cancer: Use of Minimally Invasive Techniques/Gene Expression Profiling to Predict Response and Prognosis."
The meeting is sponsored by the San Antonio Cancer Institute, a research affiliation between the Cancer Therapy and Research Center and the Health Science Center. It is supported by registration fees from the participants, corporate donations, and conference grants from the National Cancer Institute and the American Cancer Society.
Everyone must register to participate. For registration information, to view symposium abstracts and for more details about the event, visit the symposium Web site at
www.sabcs.org/Index.asp.
